Active ingredient: Each capsule contains 5.7 mg ixazomib citrate, equivalent to 4 mg ixazomib.

Excipients: Microcrystalline cellulose, magnesium stearate, talc, bovine gelatin (in capsule), titanium dioxide (E171), red iron oxide (E172), yellow iron oxide (E172), shellac, propylene glycol, potassium hydroxide, black iron oxide (E172).

Before you start using this medicine, read this INSTRUCTIONS FOR USE carefully, because it contains important information for you.

NINLARO is a light orange gelatin capsule with the words “Takeda” printed on the cap and “4 mg” on the body in black ink. Each pack contains 3 capsules.

NINLARO 4 mg capsule contains 5.7 mg ixazomib citrate, equivalent to 4 mg ixazomib.

NINLARO is a cancer medicine that contains the active ingredient ixazomib, a proteasome inhibitor.

NINLARO is used to treat a bone marrow cancer called multiple myeloma. Its active ingredient, ixazomib, works by blocking the action of proteasomes. These are structures that digest proteins within the cell and are important for the survival of the cell. Because myeloma cells produce too much protein, blocking the action of proteasomes can kill cancerous cells.

Multiple myeloma is a blood cancer that affects blood cells called plasma cells. A plasma cell is a blood cell that normally produces proteins that fight infections. Multiple myeloma patients have cancerous plasma cells called myeloma cells that damage bones. The proteins produced by these myeloma cells can damage the kidneys. Multiple myeloma treatment; It involves destroying myeloma cells and relieving the symptoms of the disease.

Instructions for proper use and dosage/frequency of application

NINLARO must be prescribed for you by a doctor experienced in treating multiple myeloma.

Use NINLARO exactly as your doctor or pharmacist tells you.

NINLARO is used together with lenalidomide (a medicine that affects how the immune system works) and dexamethasone (an anti-inflammatory medicine).

NINLARO is used together with lenalidomide and dexamethasone in 4-week (28 day) cycles.

Like all medicines, NINLARO may have side effects in people who are sensitive to its ingredients.

These side effects are listed below according to their frequency:

If any of the following occur, stop using NINLARO and IMMEDIATELY inform your doctor or go to the emergency department of your nearest hospital:

These are all very serious side effects. If you have any of these, you may need urgent medical attention or hospitalization. All of these very serious side effects are rare.

If you notice any of the following, immediately inform your doctor or go to the emergency department of your nearest hospital.

⚠️ Disclaimer: The information provided on this website is for informational purposes only and does not substitute professional medical advice. Always consult a healthcare provider before using any medication.